Ligand validation:7XFY

GOL: GLYCEROL

GOL is a Ligand Of Interest in 7XFY designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7XFY_GOL_D_203	46%	88%	0.223	0.962	0.14	0.51	-	-	0	0	100%	1
4Q8S_GOL_D_201	67%	49%	0.131	0.941	1.81	0.19	1	-	0	0	100%	1
3T2V_GOL_C_173	43%	11%	0.175	0.899	2.83	1.57	1	1	0	0	100%	1
4Q9E_GOL_D_201	40%	49%	0.204	0.916	1.82	0.19	1	-	0	0	100%	1
4ORV_GOL_D_201	35%	35%	0.203	0.891	2.26	0.42	1	-	1	0	100%	1
3C2X_GOL_C_6751	28%	58%	0.208	0.859	0.35	1.22	-	1	0	0	100%	1
1SSX_GOL_A_249	100%	72%	0.032	0.994	0.64	0.43	-	-	0	0	100%	0.8
4CJ0_GOL_A_1582	100%	73%	0.037	0.994	0.7	0.35	-	-	0	0	100%	1
7T8M_GOL_A_401	100%	41%	0.039	0.991	1.21	1.14	-	-	0	0	100%	1
4UQL_GOL_Q_1553	100%	89%	0.04	0.991	0.35	0.29	-	-	0	0	100%	1
8A3H_GOL_A_601	100%	92%	0.041	0.989	0.27	0.27	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.